Document is current
Any future updates will be listed below
-
Authors
Aetesam-ur-Rahman, Muhammad
Giblett, Joel P.
Khialani, Bharat
Kyranis, Stephen
Clarke, Sophie J.
Zhao, Tian X.
Braganza, Denise M.
Clarke, Sarah C.
West, Nick E. J.
Bennett, Martin R.
Hoole, Stephen P. https://orcid.org/0000-0003-4010-5627
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03502083 at ClinicalTrials.govDocuments that mention this clinical trial
GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated
https://doi.org/10.1186/s12872-021-02030-5
- License Information
-
More Information
Article History
Received: 12 August 2020
Accepted: 21 April 2021
First Online: 1 May 2021
Declarations
:
: The local research ethics committee (National Research Ethics Service—NRES Committee, East of England) approved the study: REC reference 14/EE/0018. All participants signed an informed consent to participate in the study and their anonymised data to be used in the subsequent publication. The study was performed according to institutional guidelines, was registered on (unique identifier: NCT03502083) and the study conformed to the principles outlined in the Declaration of Helsinki.
: Not applicable.
: The authors declare that they had no competing interests at the time of study to declare. NW has been appointed as chief medical officer for Abbott Vascular since then.
